Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2007
05/24/2007US20070117969 PTH receptor and screening assay utilizing the same
05/24/2007US20070117967 Homogeneous preparations of il-28 and il-29
05/24/2007US20070117966 Treating or preventing an alpha nu beta 3 integrin mediated disease or disorder; , imaging tissues using positron emission tomography or magnetic resonance imaging, assessing the metastatic characteristics of a tumor, and delivering DNA to a cell
05/24/2007US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof
05/24/2007US20070117753 Contacting a cell with a peptide compound capable of inducing a conformational change in Bcl-2; converting the Bcl-2 into a pro-apoptotic form
05/24/2007US20070117748 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
05/24/2007US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
05/24/2007US20070117185 Method for the recombinant expression of a polypeptide
05/24/2007US20070117181 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis
05/24/2007US20070117169 Using fluorescence-labeled glucan binding domain protein in the diagnosis of mycosis; detecting a trace amount of a fungal component
05/24/2007US20070117167 Monoclonal antibodies and methods for their use in the detection of cervical disease
05/24/2007US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes
05/24/2007US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/24/2007US20070117163 Anti-aurora-a monoclonal antibody, method for obtaining same and uses thereof for diagnosing and treating cancers
05/24/2007US20070117162 Kidney-specific urate transporter and gene thereof
05/24/2007US20070117161 Antibody Specific for Human 4-1BB Receptor
05/24/2007US20070117157 Parathyroid hormone-like polypeptides
05/24/2007US20070117156 Method of detecting native proBNP
05/24/2007US20070117141 Identification and cloning of a full-length human clnk-related gene, MIST (mast cell immunoreceptor signal transducer)
05/24/2007US20070117130 Novel activin receptor and uses thereof
05/24/2007US20070117129 Antigen arrays for treatment of bone disease
05/24/2007US20070117126 Shotgun scanning
05/24/2007US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto
05/24/2007US20070116721 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
05/24/2007US20070116716 Sars coronavirus s proteins and uses thereof
05/24/2007US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
05/24/2007US20070116707 Antibody and antibody fragments for inhibiting the growth of tumors
05/24/2007US20070116706 Antibodies to the propeptide of candida albicans and methods of use
05/24/2007US20070116704 Method for the production of an immunostimulating mucin (muc1)
05/24/2007US20070116703 Isolated mammalian membrane proteins; related agents
05/24/2007US20070116701 Compositions and methods for diagnosing and treating cancer
05/24/2007US20070116689 LIM mineralization protein splice variants
05/24/2007US20070116669 Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
05/24/2007US20070116646 Optical imaging of endometriosis
05/24/2007CA2629786A1 Human bocavirus and methods of diagnosis and treatment
05/24/2007CA2629715A1 Anti-alpha2 integrin antibodies and their uses
05/24/2007CA2629453A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
05/24/2007CA2629095A1 Anti-egfr antibodies
05/24/2007CA2628628A1 Rankl antibody-pth/pthrp chimeric molecules
05/24/2007CA2627886A1 Method for treating joint damage
05/23/2007EP1788394A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins
05/23/2007EP1788094A1 Method of distinguishing spinal cord neuron type targeting corl1 gene
05/23/2007EP1788086A1 Death Domain Containing Receptor 5
05/23/2007EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/23/2007EP1788083A1 Method of assuming drug sensitivity to cdk4 inhibitor
05/23/2007EP1787999A1 Anti-VEGF antibodies
05/23/2007EP1787998A1 Antibody and utilization of the same
05/23/2007EP1787997A1 MU-1, member of the cytokine receptor family
05/23/2007EP1786931A2 Methods and compositions for measuring natriuretic peptides and uses thereof
05/23/2007EP1786918A2 Novel tetravalent bispecific antibody
05/23/2007EP1786838A2 Compositions and methods for the diagnosis and treatment of tumor
05/23/2007EP1786837A2 Antibodies to dkk-1
05/23/2007EP1786836A2 Anti-fc-gamma riib receptor antibody and uses therefor
05/23/2007EP1786827A2 Methods for immunoglobulin purification
05/23/2007EP1786787A1 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE
05/23/2007EP1786469A2 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates
05/23/2007EP1786464A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
05/23/2007EP1786463A2 Antibodies against nogo receptor
05/23/2007EP1786450A2 Hiv immunostimulatory compositions
05/23/2007EP1364205B1 Production of a monoclonal antibody by a transgenic avian
05/23/2007EP1308512B1 Novel proteins and dnas thereof
05/23/2007EP1307537B1 Neospora caninum isolate
05/23/2007EP1029916B1 Human lysophosphatidic acid receptor and use thereof
05/23/2007EP1012274B1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l)
05/23/2007EP0873407B1 Apo-2 ligand
05/23/2007CN1968965A Phosphorylcholine conjugates and corresponding antibodies
05/23/2007CN1968712A Novel antigen-binding polypeptides and their uses
05/23/2007CN1968709A VEGF inhibitors for the treatment of malignant pleural effusion
05/23/2007CN1966526A Evolved immunoglobulin binding molecule, and its preparation method and uses
05/23/2007CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr)
05/23/2007CN1966524A Novel monoclonal antibody and nematode larval antigens
05/23/2007CN1966523A Dursban monoclonal antibody preparing method
05/23/2007CN1317563C Recombined pronucleus expression detection antigen for detecting goose parvovirus anti-body and preparing method
05/23/2007CN1317304C Fusion protein, gene encoding same, and expression method and use thereof
05/23/2007CN1317303C Anti-human tenascin monoclonal antibody
05/23/2007CN1317302C 2, 4-dichlorophen artificial antigen, and its preparing method and use
05/23/2007CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses
05/22/2007US7220841 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
05/22/2007US7220840 Antibodies that immunospecifically bind to B lymphocyte stimulator protein
05/22/2007US7220839 Useful for separating proliferative hepatocytes from a human hepatocyte population
05/22/2007US7220838 Antibodies that specifically bind hedgehog-derived polypeptides
05/22/2007US7220834 FHIT proteins and nucleic acids and methods based thereon
05/22/2007US7220832 Dermacentor variabilis GABA-gated chloride channels
05/22/2007US7220829 Cytokine binding domain of cytokine receptors
05/22/2007US7220825 Polypeptide useful for a non-invasive test for inflammatory bowel disease
05/22/2007US7220725 Pharmaceutical composition comprising an analgesic peptide and method for treating pain
05/22/2007US7220722 Lipoprotein-regulating medicants
05/22/2007US7220717 Administering formulation comprising polypeptide and muteins; For immunoregulation and/or treatment of inflammation; muteins,
05/22/2007US7220581 Comprises nucleotide sequences coding PAPAP polypeptide for diagnosing and treating psychological and nervous system disorders; drug screening
05/22/2007US7220579 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
05/22/2007US7220575 Melanoma differentiation associated gene-5 and promoter and uses thereof
05/22/2007US7220566 Subtilisin variants
05/22/2007US7220559 Development of human monoclonal antibodies and uses thereof
05/22/2007US7220556 Preparation of factor XIIIa by gene manipulation
05/22/2007US7220423 Using a genetic vaccine that codes for conserved domains 2, 3 and 5 of a major outer membrane protein (MOMP) of a strain of Chlamydia; protection against lung infections from the strain of Chlamydia trachomatis for example
05/22/2007US7220421 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
05/22/2007US7220413 Administering as wound healing or antiscarring agent for skin; surgery, injuries, fibrosis
05/22/2007US7220410 Angiogenesis inhibitors; inhibits growth of a human tumor xenograft in a mouse; cell lines; anticarcinogenic agents
05/22/2007US7220409 Stabilization of immunoglobulins at low pH
05/22/2007US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy